Engineers Gate Manager’s Co-Diagnostics CODX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-391
Closed -$14.7K 2156
2024
Q2
$14.7K Sell
391
-13
-3% -$473 ﹤0.01% 1863
2024
Q1
$13.6K Hold
404
﹤0.01% 1851
2023
Q4
$16.1K Sell
404
-40
-9% -$1.41K ﹤0.01% 1915
2023
Q3
$14.1K Hold
444
﹤0.01% 1719
2023
Q2
$14.8K Buy
444
+22
+5% +$842 ﹤0.01% 1671
2023
Q1
$18.7K Sell
422
-262
-38% -$21K ﹤0.01% 1592
2022
Q4
$51.7K Sell
684
-1,002
-59% -$93.8K ﹤0.01% 1547
2022
Q3
$162K Buy
+1,686
New +$236K 0.01% 1372
2022
Q2
Sell
-4,067
Closed -$754K 1959
2022
Q1
$754K Buy
4,067
+1,917
+89% +$397K 0.03% 837
2021
Q4
$576K Buy
2,150
+155
+8% +$40.7K 0.03% 959
2021
Q3
$582K Buy
1,995
+619
+45% +$181K 0.03% 785
2021
Q2
$341K Buy
1,376
+229
+20% +$58.9K 0.02% 1048
2021
Q1
$328K Buy
+1,147
New +$458K 0.02% 1259
2020
Q2
Sell
-933
Closed -$213K 1732
2020
Q1
$213K Buy
+933
New +$162K 0.02% 1230

Other funds holding CODX

Engineers Gate Manager's CODX Position: Q3 2024 in Review

Engineers Gate Manager sold out of Co-Diagnostics (CODX) in Q3 2024, closing a stake of 391 shares — an estimated $14.7K sold.

Engineers Gate Manager first reported a position in CODX in Q1 2020 and held it in 14 quarters. The position peaked at $754K in Q1 2022. 36 funds tracked by Wall St. Rank hold CODX as of Q3 2024.

  • Engineers Gate Manager reported no remaining Co-Diagnostics position as of Q3 2024 after selling out during the quarter.
  • Engineers Gate Manager sold 391 Co-Diagnostics shares in Q3 2024, an estimated $14.7K.
  • Engineers Gate Manager first reported a position in Co-Diagnostics in Q1 2020 and held it in 14 quarters.
  • Engineers Gate Manager's Co-Diagnostics position peaked at $754K in Q1 2022.
  • 36 funds tracked by Wall St. Rank held Co-Diagnostics as of Q3 2024.

Based on Engineers Gate Manager's 13F filing for Q3 2024, filed 14 Nov 2024.